United States · FDA National Drug Code directory
Oralair 300 IR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59617-0015_37291a56-277d-dd3a-e063-6294a90a7571
- Product NDC
- 59617-0015
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- ANTHOXANTHUM ODORATUM POLLEN, DACTYLIS GLOMERATA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, and POA PRATENSIS POLLEN
- Labeler
- Stallergenes
- Marketing category
- BLA
- Marketing start / end (source format)
- 20140430
- Source listing expiry
- 20261231
Source-listed ingredients
- DACTYLIS GLOMERATA POLLEN — 300 [IR]/1
- ANTHOXANTHUM ODORATUM POLLEN — 300 [IR]/1
- LOLIUM PERENNE POLLEN — 300 [IR]/1
- PHLEUM PRATENSE POLLEN — 300 [IR]/1
- POA PRATENSIS POLLEN — 300 [IR]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (59617-0015-2) · 59617-0015-2
- 1 BLISTER PACK in 1 BOX (59617-0015-3) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59617-0015-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →